1-2 of 2
DiJun Zhao
Close
Save search
Sort by
Journal Articles

An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma

Free
Gang An, MD PhD, Weiwei Sui, MD, Tingyu Wang, Xiaoyan Qu, MD PhD, Xian Zhang, MD, Junfang Yang, Yan Zhang, MD, Lu Zhang, MD, Judy Zhu, MD, Chengxiao Zheng, MD, Xiuxiu Yan, Xiaoteng Lv, MS, Liping Lan, MS, Dingzhu Yang, Ningning Huo, Ting Han, MS, Dijun Zhao, MS, Shichao Qin, Junfeng Wu, PhD, Xin Yao, PhD, Shigui Zhu, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Jiaqi Huang, PhD, Michael Humphries, MD, Yihong Yao, PhD, Daobin Zhou, MD PhD, Jianyong Li, MD PhD, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-138734
Published: 2020
Journal Articles

Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma

Free
Xin Yao, PhD, Shigui Zhu, PhD, Jiaqi Huang, PhD, Xiaoyan Qu, MD PhD, Judy Zhu, MD, Yutian Wei, MS, Liping Lan, MS, Xiaoteng LV, MS, Junfeng Wu, PhD, Rirfei Wang, MS, Dingzhu Yang, Chengxiao Zheng, MD, DiJun Zhao, MS, Lei Fan, MD PhD, Fei Huang, Hua Lu, MD PhD, Chaocan Zhang, MS, Cheng Chen, PhD, Yanfeng Li, MS, Jiaqiang Ren, MD PhD, Li Zhang, MD, Michael Humphries, MD, Jianyong Li, MD, Yihong Yao, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 50.
https://doi.org/10.1182/blood-2019-125372
Published: 2019